Move seen as attempt to fend off Takeda takeover
CEO Weber wants to turn Takeda into global pharma
Shares in the UK-based Shire Pharma have surged upwards after Takeda has disclosed that it is considering a takeover bid.
Generics and biosimilars to drive growth, according to report.
Decision follows EU regulators’ decision to back Crohn’s stem cell therapy
After Sativex disappointment, Epidiolex could transform GW’s fortunes.
Japanese firm wants to build presence in cancer